- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
JFR 2008 puts emphasis on high-tech imaging
High-tech imaging was the central theme of the 56th Journées Françaises de Radiologie (JFR), held in Paris from 24 to 28 October. Left: DI Europe's editorial advisor, Prof. Andy Adam from London, was one of three honorary members at the congress.
High-tech imaging was the central theme of the 56th Journées Françaises de Radiologie (JFR), held in Paris from 24 to 28 October. Left: DI Europe's editorial advisor, Prof. Andy Adam from London, was one of three honorary members at the congress. The other two honorary members were Prof. Lluís Donoso Bach from Barcelona and Dr. James Thrall from Boston, Massachusetts. Middle: The general assembly of the Fédération Nationale des Médecins Radiologues took place during the JFR. FNMR president Dr. Jacques Niney informed attendees about the ongoing reforms and reductions in fees that might lie ahead. Right: The Société Française de Radiologie's reception took place at the Hôtel des Invalides. (Photos by Dr. Robert Lavayssière)
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
